Axogen (LTS:0HKD) Ending Cash Position : $37.0 Mil (As of Dec. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Axogen Ending Cash Position?

Axogen's Ending Cash Position for the quarter that ended in Dec. 2023 was $37.0 Mil.

Axogen's quarterly Ending Cash Position increased from Jun. 2023 ($29.5 Mil) to Sep. 2023 ($37.1 Mil) but then declined from Sep. 2023 ($37.1 Mil) to Dec. 2023 ($37.0 Mil).

Axogen's annual Ending Cash Position declined from Dec. 2021 ($39.0 Mil) to Dec. 2022 ($21.5 Mil) but then increased from Dec. 2022 ($21.5 Mil) to Dec. 2023 ($37.0 Mil).

Axogen Ending Cash Position Historical Data

The historical data trend for Axogen's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Axogen Ending Cash Position Chart

Axogen Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Ending Cash Position

Get a 7-Day Free Trial

41.72

55.61

39.01

21.54

37.03

Axogen Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Ending Cash Position	Get a 7-Day Free Trial															21.54	13.96	29.47	37.10	37.03

Axogen Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Axogen's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	21.535	+	15.491
	=	37.0

Axogen's Ending Cash Position for the quarter that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	37.096	+	-0.07
	=	37.0

Axogen Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Axogen's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Axogen (LTS:0HKD) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Axogen Inc (LTS:0HKD) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

AXGN:USA LT3:Germany

Address

13631 Progress Boulevard, Suite 400, Alachua, FL, USA, 32615

Website

https://www.axogeninc.com

Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically, economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, South Korea, and several other countries.

Axogen (LTS:0HKD) Headlines

No Headlines